Asaad G Beshish, Joshua Qian, Kasey Keane-Lerner, Paola Rodriguez Morales, Rebecca Shamah, Tawanda Zinyandu, Pranay Nayi, Joel Davis, Joshua M Rosenblum, Heather K Viamonte
{"title":"Acute Kidney Injury and Outcomes in Infants, Children, and Adolescents, Supported With Extracorporeal Life Support for Cardiopulmonary Failure.","authors":"Asaad G Beshish, Joshua Qian, Kasey Keane-Lerner, Paola Rodriguez Morales, Rebecca Shamah, Tawanda Zinyandu, Pranay Nayi, Joel Davis, Joshua M Rosenblum, Heather K Viamonte","doi":"10.1097/MAT.0000000000002321","DOIUrl":null,"url":null,"abstract":"<p><p>In neonatal and pediatric patients who require extracorporeal life support (ECLS), 60-70% develop acute kidney injury (AKI). Acute kidney injury has been associated with increased morbidity and mortality. We sought to describe our center's experience with AKI in patients requiring ECLS and its effect on outcomes. We conducted a retrospective single-center study at an academic children's hospital. All patients 0-18 years of age who required ECLS between January 2014 and December 2019. During the study period, there were 313 ECLS runs. The majority were neonates (66.8%) and 68.7% of runs were veno-arterial. Using Kidney Disease Improving Global Outcomes (KDIGO) criteria, 227 patients (72.5%) developed stage 2 or 3 AKI. The AKI group were younger (median age: 0.9 vs. 11.7 months, p < 0.001), more likely to experience a hemorrhagic complication (46.9% vs. 31.9%, p = 0.0298), and had higher mortality rates (44.9% vs. 24.4%, p = 0.0009). Neonates who required ECLS were more likely to develop stage 2 or 3 AKI (78%) than pediatrics (63%) (p = 0.005). Adjusting for confounders, patients who developed AKI had 2.38 times higher odds of mortality (95% confidence interval [CI]: 1.34-4.25, p = 0.003). We conclude that the majority of patients requiring ECLS develop stage 2 or 3 AKI. Those with AKI were twice as likely to die when controlling for confounding variables. Multicenter and prospective evaluation of this modifiable risk factor is imperative to improve the care of this high-risk cohort.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASAIO Journal","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1097/MAT.0000000000002321","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
In neonatal and pediatric patients who require extracorporeal life support (ECLS), 60-70% develop acute kidney injury (AKI). Acute kidney injury has been associated with increased morbidity and mortality. We sought to describe our center's experience with AKI in patients requiring ECLS and its effect on outcomes. We conducted a retrospective single-center study at an academic children's hospital. All patients 0-18 years of age who required ECLS between January 2014 and December 2019. During the study period, there were 313 ECLS runs. The majority were neonates (66.8%) and 68.7% of runs were veno-arterial. Using Kidney Disease Improving Global Outcomes (KDIGO) criteria, 227 patients (72.5%) developed stage 2 or 3 AKI. The AKI group were younger (median age: 0.9 vs. 11.7 months, p < 0.001), more likely to experience a hemorrhagic complication (46.9% vs. 31.9%, p = 0.0298), and had higher mortality rates (44.9% vs. 24.4%, p = 0.0009). Neonates who required ECLS were more likely to develop stage 2 or 3 AKI (78%) than pediatrics (63%) (p = 0.005). Adjusting for confounders, patients who developed AKI had 2.38 times higher odds of mortality (95% confidence interval [CI]: 1.34-4.25, p = 0.003). We conclude that the majority of patients requiring ECLS develop stage 2 or 3 AKI. Those with AKI were twice as likely to die when controlling for confounding variables. Multicenter and prospective evaluation of this modifiable risk factor is imperative to improve the care of this high-risk cohort.
在需要体外生命支持(ECLS)的新生儿和儿科患者中,60-70%发生急性肾损伤(AKI)。急性肾损伤与发病率和死亡率增加有关。我们试图描述本中心在需要ECLS的患者中处理AKI的经验及其对结果的影响。我们在一家学术儿童医院进行了一项回顾性单中心研究。所有在2014年1月至2019年12月期间接受ECLS治疗的0-18岁患者。在研究期间,共进行了313次ECLS检查。大多数为新生儿(66.8%),68.7%为静脉-动脉流。使用肾脏疾病改善全球预后(KDIGO)标准,227名患者(72.5%)发展为2期或3期AKI。AKI组更年轻(中位年龄:0.9 vs 11.7个月,p < 0.001),更容易出现出血性并发症(46.9% vs. 31.9%, p = 0.0298),死亡率更高(44.9% vs. 24.4%, p = 0.0009)。需要ECLS的新生儿(78%)比儿科(63%)更有可能发展为2期或3期AKI (p = 0.005)。调整混杂因素后,发生AKI的患者死亡率高出2.38倍(95%可信区间[CI]: 1.34-4.25, p = 0.003)。我们得出结论,大多数需要ECLS的患者发展为2期或3期AKI。在控制混杂变量后,AKI患者的死亡率是其他患者的两倍。对这一可改变的危险因素进行多中心和前瞻性评估对于改善这一高危人群的护理是必要的。
期刊介绍:
ASAIO Journal is in the forefront of artificial organ research and development. On the cutting edge of innovative technology, it features peer-reviewed articles of the highest quality that describe research, development, the most recent advances in the design of artificial organ devices and findings from initial testing. Bimonthly, the ASAIO Journal features state-of-the-art investigations, laboratory and clinical trials, and discussions and opinions from experts around the world.
The official publication of the American Society for Artificial Internal Organs.